FDA
has strengthened the warnings and precautions sections in the labeling of OxyContin
(oxycodone HCl controlled-release) Tablets, a narcotic drug approved for the treatment
of moderate to severe pain.
In
recent months, there have been numerous reports of OxyContin diversion and abuse
in several states. Some of these reported cases have been associated with serious
consequences including death. In an effort to educate health care providers about
these risks, Purdue Pharmaceuticals, manufacturer of the product, has issued a
warning in the form of a "Dear Healthcare Professional" letter. The
"Dear Healthcare Professional" letter will be distributed widely to
physicians, pharmacists, and other healthcare professionals.
*Many cases are in
the investigative stages, but make a complaint now and your case can be evaluated.
Find out if you are owed money for damages and injury?